Literature DB >> 24006327

Determinants of the species selectivity of oxazolidinone antibiotics targeting the large ribosomal subunit.

Jagmohan S Saini, Nadine Homeyer, Simone Fulle, Holger Gohlke.   

Abstract

Oxazolidinone antibiotics bind to the highly conserved peptidyl transferase center in the ribosome. For developing selective antibiotics, a profound understanding of the selectivity determinants is required. We have performed for the first time technically challenging molecular dynamics simulations in combination with molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) free energy calculations of the oxazolidinones linezolid and radezolid bound to the large ribosomal subunits of the eubacterium Deinococcus radiodurans and the archaeon Haloarcula marismortui. A remarkably good agreement of the computed relative binding free energy with selectivity data available from experiment for linezolid is found. On an atomic level, the analyses reveal an intricate interplay of structural, energetic, and dynamic determinants of the species selectivity of oxazolidinone antibiotics: A structural decomposition of free energy components identifies influences that originate from first and second shell nucleotides of the binding sites and lead to (opposing) contributions from interaction energies, solvation, and entropic factors. These findings add another layer of complexity to the current knowledge on structure-activity relationships of oxazolidinones binding to the ribosome and suggest that selectivity analyses solely based on structural information and qualitative arguments on interactions may not reach far enough. The computational analyses presented here should be of sufficient accuracy to fill this gap.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006327     DOI: 10.1515/hsz-2013-0188

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  5 in total

1.  Complex long-distance effects of mutations that confer linezolid resistance in the large ribosomal subunit.

Authors:  Simone Fulle; Jagmohan S Saini; Nadine Homeyer; Holger Gohlke
Journal:  Nucleic Acids Res       Date:  2015-07-21       Impact factor: 16.971

Review 2.  New developments in the management of severe skin and deep skin structure infections - focus on tedizolid.

Authors:  Michael J Durkin; G Ralph Corey
Journal:  Ther Clin Risk Manag       Date:  2015-05-22       Impact factor: 2.423

Review 3.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

Review 4.  Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.

Authors:  Darrell McBride; Tamara Krekel; Kevin Hsueh; Michael J Durkin
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-02-16       Impact factor: 4.481

5.  Molecular Mechanisms of Glutamine Synthetase Mutations that Lead to Clinically Relevant Pathologies.

Authors:  Benedikt Frieg; Boris Görg; Nadine Homeyer; Verena Keitel; Dieter Häussinger; Holger Gohlke
Journal:  PLoS Comput Biol       Date:  2016-02-02       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.